Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhuhai Tongyi Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of both Western medicines and Traditional Chinese Medicines (TCM). The company's product portfolio primarily focuses on anti-infectives, respiratory treatments, and cardiovascular health, with well-known products such as compound paracetamol and various antibiotic formulations. Operating out of Zhuhai, the company maintains GMP-certified manufacturing facilities to ensure high-quality production standards for the domestic market. Tongyi Pharmaceutical is recognized for its established presence in the Chinese retail and hospital sectors, providing essential medications for common ailments. The company continues to leverage its "Tongyi" brand to expand its footprint in the healthcare industry through a combination of modern chemical synthesis and traditional herbal extraction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Tongyi Pharmaceutical.